The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...
The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.
UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...
If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...
Dr. Stephen Wasserman answers the question: 'What Is A Rescue Medicine?' — -- Question: What is a rescue medicine and when is it used for asthma? Answer: A rescue medicine is a medicine used in ...
Confused about your asthma medications? Here's what you need to know to sort out the main classes and numerous subtypes of asthma drugs. The types and doses of asthma medications you need depend on ...
Sandoz Group Ltd ($SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is conducting a clinical study ...
This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...
Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...
Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains high, according to an observational study. From 2011-2022, ...
When Jacqueline Vakil needed a refill for Flovent, her 4-year-old son’s asthma medicine, she couldn’t get it. The drugmaker GSK had stopped making the popular inhaler, back in January. To make matters ...
August 8, 2011 — Controller medications and follow-up are underused in young patients hospitalized for asthma, according to the results of a retrospective analysis of South Carolina Medicaid data from ...